Evaluation of a Nomogram used to predict the pathologic stage of clinically localized prostate carcinoma
✍ Scribed by Michael W. Kattan; Alan M. F. Stapleton; Thomas M. Wheeler; Peter T. Scardino
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 140 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
BACKGROUND. A Nomogram based on pretreatment prostate specific antigen (
📜 SIMILAR VOLUMES
## BACKGROUND. The current study assesses artificial intelligence methods to identify prostate carcinoma patients at low risk for lymph node spread. If patients can be assigned accurately to a low risk group, unnecessary lymph node dissections can be avoided, thereby reducing morbidity and costs.
## BACKGROUND. Accurate examination of radical cystectomy specimens is critical for stratifying patients into prognostically important groups and determining the need for adjuvant treatment. Evidence has accumulated that cancers invading the superficial muscle wall (T2a) behave similarly to those